This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
[Advances in Pharmacology] Antiviral Agents Volume 67 || Index
โ Scribed by ,
- Book ID
- 121256017
- Publisher
- Elsevier
- Year
- 2013
- Tongue
- English
- Weight
- 215 KB
- Edition
- 1
- Category
- Article
- ISBN
- 0124058809
- ISSN
- 1054-3589
No coin nor oath required. For personal study only.
โฆ Synopsis
This new volume of Advances in Pharmacology explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike.
- Explores the current state of anti-viral agents
- Chapters cover a variety of topics such as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV
- With the best authors in the field, the volume is an essential resource for pharmacologists, immunologists and biochemists alike
๐ SIMILAR VOLUMES
This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
This new volume of *Advances in Pharmacology* explores the current state of antiviral agents. Chapters cover such topics as virus entry inhibitors, interferon-free drug combinations, and antiviral agents for HSV. With a variety of chapters and the best authors in the field, the volume is an essentia
This new volume of *Advances in Pharmacology* explores the current state of Alzheimer's disease research and therapeutics. Chapters cover such topics as the **B cell targeted therapies**, **Lymphotoxin family receptors in inflammation**, and **allergic inflammation and thymic stromal lymphopoietin**